Towarzystwo Funduszy Inwestycyjnych PZU SA’s Alnylam Pharmaceuticals ALNY Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$162K	Buy	538 +70	+15%	+$21.1K	0.05%	229
2026 Q1	$155K	Sell	468 -62	-12%	-$21.1K	0.05%	210
2025 Q4	$211K	Hold	530	–	–	0.05%	178
2025 Q3	$242K	Sell	530 -572	-52%	-$233K	0.06%	156
2025 Q2	$359K	Sell	1,102 -60	-5%	-$16.6K	0.1%	106
2025 Q1	$314K	Buy	1,162 +160	+16%	+$41.1K	0.11%	97
2024 Q4	$236K	Sell	1,002 -198	-17%	-$52.1K	0.08%	110
2024 Q3	$330K	Buy	1,200 +350	+41%	+$91.1K	0.12%	77
2024 Q2	$207K	Hold	850	–	–	0.08%	110
2024 Q1	$127K	Hold	850	–	–	0.05%	160
2023 Q4	$163K	Buy	+850	New	+$145K	0.07%	113
2021 Q3	$28.3K	Buy	+150	New	+$28.1K	0.03%	217

Other funds holding ALNY

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's ALNY Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Alnylam Pharmaceuticals (ALNY) stake by 15% in Q2 2026, buying an estimated $21.1K and bringing the position to 538 shares worth $162K. The position accounts for 0.05% of the portfolio, ranked #229.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ALNY in Q3 2021 and has held it in 12 quarters since. The position peaked at $359K in Q2 2025. 497 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Towarzystwo Funduszy Inwestycyjnych PZU SA held 538 shares of Alnylam Pharmaceuticals worth $162K as of Q2 2026.
Towarzystwo Funduszy Inwestycyjnych PZU SA bought 70 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $21.1K.
Alnylam Pharmaceuticals made up 0.05% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #229 holding.
Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Alnylam Pharmaceuticals in Q3 2021 and has held it in 12 quarters since.
Towarzystwo Funduszy Inwestycyjnych PZU SA's Alnylam Pharmaceuticals position peaked at $359K in Q2 2025.
497 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.